No glycemic benefit from guar administration in NIDDM.
A randomized crossover study of 5-g guar minitablets against placebo, given three times per day with main meals for 8 wk, was done in 29 non-insulin-dependent diabetes mellitus (NIDDM) patients who had near-normal fasting plasma glucose concentrations on treatment with diet alone, additional sulfony...
Auteurs principaux: | Holman, R, Steemson, J, Darling, P, Turner, R |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
1987
|
Documents similaires
-
LACK OF BENEFIT FROM GUAR ADMINISTRATION IN WELL CONTROLLED NON-INSULIN-DEPENDENT DIABETIC-PATIENTS
par: Holman, R, et autres
Publié: (1984) -
Insulin use in NIDDM. Rationale based on pathophysiology of disease.
par: Turner, R, et autres
Publié: (1990) -
Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals
par: Cull, C, et autres
Publié: (1997) -
Effects of ethnicity on metabolic control during the first six years of NIDDM
par: Davis, T, et autres
Publié: (1997) -
Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
par: Turner, R, et autres
Publié: (1997)